United Therapeutics Corporation annual net income for fiscal 2025 was $1.3 billion, an increase of 11.7% from $1.2 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $1.3B | $1.2B | $985M | $727M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Net Income | $275M | $364M | $339M | $310M | $322M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More UTHR metrics: Revenue · Gross Profit · Operating Income · EPS · Free Cash Flow
All UTHR financial statements → Interactive UTHR charts →
About TickerBase · Data methodology & sources